4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-015096
VP Clinical Reg Affairs bought 250 shares at $11.22 ($2,805)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2023-04-28 | Purchase | +250 | $11.22 | $2,805 | 258,998 | D |
| Open-market purchases · 250 sh · avg $11.22 · $2,805 | |||||||
Loading xslF345X04/ownership.xml…